S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money

Eliem Therapeutics (ELYM) SEC Filings & 10K Form

$4.31
-0.27 (-5.90%)
(As of 04/12/2024 ET)

Recent Eliem Therapeutics SEC Filings

DateFilerForm TypeView
04/12/2024
5:52 PM
Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
04/11/2024
7:01 AM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
7:10 AM
Eliem Therapeutics (Filer)
Form DEFA14A
04/08/2024
4:33 PM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:05 PM
Eliem Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2024
3:33 PM
Eliem Therapeutics (Issuer)
Pimblett Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
10:07 AM
Eliem Therapeutics (Issuer)
Morisset Valerie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
10:53 AM
BML Investment Partners, L.P. (Filed by)
Eliem Therapeutics (Subject)
Form SC 13G/A
11/17/2023
3:30 PM
Eliem Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
11/14/2023
3:01 PM
Eliem Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2023
4:13 PM
AI ETI LLC (Filed by)
Eliem Therapeutics (Subject)
Form SC 13D/A
07/20/2023
5:55 AM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
4:08 PM
Dunn Judith (Reporting)
Eliem Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
4:11 PM
Eliem Therapeutics (Issuer)
Ratcliffe Liam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
4:13 PM
Eliem Therapeutics (Issuer)
Tate Simon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2023
4:22 PM
Eliem Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2023
3:45 PM
Eliem Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ELYM) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners